Recombinant Influenza A H3N2 (A/Aichi/2/1968) Matrix protein 1 / M1 Protein (His Tag) Antigens The influenza A virus (A/Aichi/2/1968(H3N2)) matrix protein 1 (AFM71858.1) (Met1-Lys252), termed as M1, was fused with a N-terminal polyhistidine tag. The recombinant M1 subunit of influenza A H3N2 consists of 268a.a and has a predicted molecular weight of 30 kDa. It migrates as an approximately 35 kDa band in SDS-PAGE under reducing conditions.
$ $99 In stock
Formulation: The recombinant M1 subunit of influenza A H3N2 consists of 268a.a and has a predicted molecular weight of 30 kDa. It migrates as an approximately 35 kDa band in SDS-PAGE under reducing conditions.
Source: E. coli
Usage: Our products are for research use only. This product is not intended or approved for human, diagnostics or veterinary use.

Recombinant Influenza A H3N2 (A/Aichi/2/1968) Matrix protein 1 / M1 Protein (His Tag)

The product is for non-human research only. Not for therapeutic or veterinary use.

Catalog Number: BT-224528

Molecular Weight: The recombinant M1 subunit of influenza A H3N2 consists of 268a.a and has a predicted molecular weight of 30 kDa. It migrates as an approximately 35 kDa band in SDS-PAGE under reducing conditions.

Formulation: Recombinant Influenza A H3N2 (A/Aichi/2/1968) Matrix Protein was lyophilized from sterile 1mM EDTA, 50mM Tris, 50mM NaCl, 5% glycerol.1.

Source: E. coli

Product Name Recombinant Influenza A H3N2 (A/Aichi/2/1968) Matrix protein 1 / M1 Protein (His Tag)
Molecular Weight The recombinant M1 subunit of influenza A H3N2 consists of 268a.a and has a predicted molecular weight of 30 kDa. It migrates as an approximately 35 kDa band in SDS-PAGE under reducing conditions.
AA Sequence Met1-Lys252
Bioactivity Please contact us for detailed information
Formulation Recombinant Influenza A H3N2 (A/Aichi/2/1968) Matrix Protein was lyophilized from sterile 1mM EDTA, 50mM Tris, 50mM NaCl, 5% glycerol.1.
Description The influenza A virus (A/Aichi/2/1968(H3N2)) matrix protein 1 (AFM71858.1) (Met1-Lys252), termed as M1, was fused with a N-terminal polyhistidine tag.
Product Background Influenza virus matrix protein 1 (M1) has been shown to play a crucial role in the virus replication, assembly and budding.The matrix protein 1 (M1) is the most abundant structural protein in influenza A virus particles.Matrix protein 1 (M1) of the influenza A virus plays multiple roles in virion assembly and infection. M1 protein was a candidate antigen for a broad-spectrum influenza virus vaccine and the adjuvant chitosan significantly improved the efficacy of the M1 vaccine.
Product Type Antigen
Purity Greater than 85% as determined by SDS-PAGE
Source E. coli
Storage Store recombinant protein under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Terminal His
Usage Our products are for research use only. This product is not intended or approved for human, diagnostics or veterinary use.
Last Modified Aug 20 2021